s
WestGene to Advance Clinical Trials Following Dual IND Approvals for World’s First EB Virus-Related mRNA Therapeutic Cancer Vaccine
08-08-2024, 08:25
CHENGDU, China, Aug. 8, 2024 /PRNewswire/ — WestGene Biopharma is proud to announce that its mRNA therapeutic cancer vaccine, WGc-043, has received dual IND approvals from China’s National Medical Products Administration (NMPA) and the US FDA. This unprecedented achievement marks the world’s first IND-approved mRNA vaccine for EBV-related cancers in both the United States and […] L'articolo WestGene to Advance Clinical Trials Following Dual IND Approvals for World’s First EB Virus-Related mRNA Therapeutic Cancer Vaccine proviene da La Ragione.
CONTINUA A LEGGERE
11
0
0
Guarda anche
La Ragione
09:43
Italpress €conomy – Puntata del 20 settembre 2024
La Ragione
09:05
Mercedes: taglia stime utili 2024 su problemi mercato Cina
La Ragione
08:59